RenaissanceRe Holdings Ltd.

Fundamentals8.0
Price Action5.6
News Sentiment0.0
AI Rating
6.9

Key Drivers

  • Strong Cash Flow
  • Improving Margins
  • Leverage Risk

AI
AI Summary

6.9

RNR now looks more like a high-quality compounding insurer than a premium-growth re-rating story, with strong underwriting, rising investment income, and buybacks supporting earnings and book value, but upside appears limited near current valuation and the main risks remain catastrophe losses, reserve volatility, and a weaker rate backdrop.

Compounding
ValuationRisk
Reinsurance‍

Price Chart

Loading chart...

Financial Metrics

-
Revenue (TTM)
-
Net Income (TTM)
-
EPS (Q)
-
MCAP

Deep Analysis

Research tool. Not personalized advice.

Fundamental Analysis

8.0

Key Financial Insights:

  • Strong Cash Flow
  • Improving Margins
  • Leverage Risk

RNR looks inexpensive with improving profitability, strong cash generation, and a solid liquidity cushion, but its high leverage and investment-portfolio dependence remain the main risks.

undervalued
leveraged

Price Behavior

5.6
Research tool. Not personalized advice. Technical analysis is for informational purposes only.

Key Price Behavior Insights:

  • Range-bound trade
  • Support holding
  • Resistance capped

Over the last month, RNR has been range-bound with a slight positive bias, holding $316.50-$319.00 support but still capped by $328.90-$334.25 resistance.

sideways
watchlist
Support Level: $316.50-$319.00
Resistance Level: $328.90-$334.25

Sharp drop from $332.61 to $318.36, followed by a recovery and sideways consolidation

Sentiment & News

0.0

Key News Insights:

  • EPS Beat
  • Strong ROE
  • Buyback Boost

RenaissanceRe's Q2 2026 results beat expectations on stronger investment income, lower expenses, and a better combined ratio, supporting solid earnings growth and renewed capital returns.

EarningsBeat
CapitalReturn

The results should be supportive for RNR shares as they offset weaker premiums and reinforce confidence in earnings quality and shareholder returns